易瑞生物 (300942.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(易瑞生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 54,399,597.0567,173,222.7536,475,073.4589,007,201.8752,987,958.3051,403,742.2460,707,585.25
 营业收入(元) 54,399,597.0567,173,222.7536,475,073.4589,007,201.8752,987,958.3051,403,742.2460,707,585.25
二、营业总成本(元) 56,248,814.0058,228,871.6544,390,455.7287,804,991.4459,674,367.3390,638,271.8094,325,423.68
 营业成本(元) 21,081,178.6723,249,122.259,258,401.0342,587,899.9616,613,723.2822,508,126.4245,522,665.69
 研发费用(元) 8,682,987.459,840,458.2710,280,504.624,533,964.138,101,702.6022,115,785.9318,391,842.45
 营业税金及附加(元) 238,339.06180,910.26101,240.55371,327.442,458,533.82366,882.15480,006.77
 销售费用(元) 10,191,364.5013,484,017.379,732,419.013,746,293.0513,650,582.2822,734,058.2816,621,519.54
 管理费用(元) 11,482,160.6412,000,314.4512,772,224.7132,891,918.1917,034,459.0530,524,931.0613,980,882.24
 财务费用(元) 4,572,783.68-525,950.952,245,665.803,673,588.671,815,366.30-7,611,512.04-671,493.01
  其中:利息费用(元) 3,803,341.992,881,534.095,394,782.256,129,883.46961,366.082,357,213.211,180,065.09
  其中:利息收入(元) 1,204,120.362,777,642.982,818,626.921,546,445.242,053,174.206,202,230.62-2,244,905.53
 资产减值损失(元) ----39,417,026.29-4,385,770.24--
 信用减值损失(元) -1,715,930.49-4,316,935.35546,959.05-993,024.42-2,167,879.10-1,970,188.721,611,479.50
三、其他经营收益
 加:公允价值变动收益(元) 1,878,106.74265,822.0489,240.29-124,028.40-52,320.0799,750.00
 加:投资收益(元) -3,003,782.43-1,376,622.45-1,663,633.85-46,162,891.08-2,814,633.43-1,415,909.78-3,718,625.02
  其中:对联营企业和合营企业的投资收益(元) -3,774,785.91-2,087,032.29-2,159,496.86-46,350,357.06-3,025,516.99-1,776,238.55-3,718,625.02
 资产处置收益(元) 1,585,364.21909,939.80177,634.86221,277.44454,128.942,114,281.0420,525.58
 其他收益(元) 9,500,805.271,771,800.521,422,804.835,058,632.314,307,198.372,840,272.502,070,494.55
四、营业利润(元) 6,211,511.176,198,355.66-7,342,377.09-80,214,850.01-11,293,364.49-50,258,758.50-33,534,213.82
 加:营业外收入(元) 136,109.341,926.5012,653.03103,070.84114,422.85664,417.1393,239.42
 减:营业外支出(元) 390,512.53--1,447,462.681,064,802.00957,330.852,411.99
五、利润总额(元) 5,957,107.986,091,802.26-7,329,724.06-81,559,241.85-12,243,743.64-50,551,672.22-33,443,386.39
 减:所得税费用(元) 1,017,053.54770,865.72-55,961.404,207,501.5917,296,977.98-8,961,176.81-5,357,991.55
六、净利润(元) 4,940,054.445,320,936.54-7,273,762.66-85,766,743.44-29,540,721.62-41,590,495.41-28,085,394.84
(一)按经营持续性分类
  持续经营净利润(元) 4,940,054.445,320,936.54-7,273,762.66-85,766,743.44-29,540,721.62-41,590,495.41-28,085,394.84
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 5,456,465.065,551,579.72-7,111,078.14-85,749,215.40-29,526,261.20-41,571,178.10-28,061,115.03
  少数股东损益(元) -516,410.62-230,643.18-162,684.52-17,528.04-14,460.42-19,317.31-24,279.81
 扣除非经常性损益后的净利润(元) -4,611,154.993,159,469.95-8,418,548.53-85,562,488.09-32,765,926.00-45,761,762.70-29,816,754.26
七、每股收益
 一、基本每股收益(元) 0.010.02-0.02-0.21-0.08-0.10-0.07
 二、稀释每股收益(元) 0.010.02-0.02-0.21-0.08-0.10-0.07
八、其他综合收益(元) -63,387.3464,803.10-66,277.39-1,402,784.75-818,913.382,579,052.1843,114.26
 归属于母公司股东的其他综合收益(元) -63,387.3464,803.10-66,277.39-1,402,784.75-818,913.382,579,052.1843,114.26
九、综合收益总额(元) 4,876,667.105,385,739.64-7,340,040.05-87,169,528.19-30,359,635.00-39,011,443.23-28,042,280.58
 归属于母公司所有者的综合收益总额(元) 5,393,077.725,616,382.82-7,177,355.53-87,152,000.15-30,345,174.58-38,992,125.92-28,018,000.77
 归属于少数股东的综合收益总额(元) -516,410.62-230,643.18-162,684.52-17,528.04-14,460.42-19,317.31-24,279.81
公告日期 2024-10-292024-08-302024-04-262024-04-262023-10-272023-08-302023-04-26
审计意见(境内) 标准无保留意见

前瞻产业研究院